Your browser doesn't support javascript.
loading
Immunoselection techniques in hematopoietic stem cell transplantation.
Li Pira, Giuseppina; Biagini, Simone; Cicchetti, Elisabetta; Merli, Pietro; Brescia, Letizia Pomponia; Milano, Giuseppe Maria; Montanari, Mauro.
Afiliação
  • Li Pira G; Department of Pediatric Hematology and Oncology, Unit of Immuno-Hematology and Transfusion Medicine, IRCCS Bambino Gesù Children's Hospital, Rome, Italy. Electronic address: giuseppina.lipira@opbg.net.
  • Biagini S; Department of Pediatric Hematology and Oncology, Unit of Immuno-Hematology and Transfusion Medicine, IRCCS Bambino Gesù Children's Hospital, Rome, Italy.
  • Cicchetti E; Department of Pediatric Hematology and Oncology, Unit of Immuno-Hematology and Transfusion Medicine, IRCCS Bambino Gesù Children's Hospital, Rome, Italy.
  • Merli P; Department of Pediatric Hematology and Oncology, Unit of Immuno-Hematology and Transfusion Medicine, IRCCS Bambino Gesù Children's Hospital, Rome, Italy.
  • Brescia LP; Department of Pediatric Hematology and Oncology, Unit of Immuno-Hematology and Transfusion Medicine, IRCCS Bambino Gesù Children's Hospital, Rome, Italy.
  • Milano GM; Department of Pediatric Hematology and Oncology, Unit of Immuno-Hematology and Transfusion Medicine, IRCCS Bambino Gesù Children's Hospital, Rome, Italy.
  • Montanari M; Department of Pediatric Hematology and Oncology, Unit of Immuno-Hematology and Transfusion Medicine, IRCCS Bambino Gesù Children's Hospital, Rome, Italy.
Transfus Apher Sci ; 54(3): 356-63, 2016 Jun.
Article em En | MEDLINE | ID: mdl-27209628
Hematopoietic Stem Cells Transplantation (HSCT) is an effective treatment for hematological and non-hematological diseases. The main challenge in autologous HSCT is purging of malignant cells to prevent relapse. In allogeneic HSCT graft-versus-host disease (GvHD) and opportunistic infections are frequent complications. Two types of graft manipulation have been introduced: the first one in the autologous context aimed at separating malignant cells from hematopoietic stem cells (HSC), and the second one in allogeneic HSCT aimed at reducing the incidence of GvHD and at accelerating immune reconstitution. Here we describe the manipulations used for cell purging in autologous HSCT or for T Cell Depletion (TCD) and T cell selection in allogeneic HSCT. More complex manipulations, requiring a Good Manufacturing Practice (GMP) facility, are briefly mentioned.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Depleção Linfocítica / Doença Enxerto-Hospedeiro Limite: Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Depleção Linfocítica / Doença Enxerto-Hospedeiro Limite: Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article